| |
---|
| Detailed Price Information Link |
PLASMIDS | |
Name: | pAM77 |
DSM No.: | 4751 dsm-4751 dsm4751 dsm 4751 pAM77 |
Other collection no. or WDCM no.: | BGSC 1E34 |
History: | <- BGSC <- B. Weisblum |
Mol. weight: | 6.8 kb |
Marker: | Emr |
Remarks: | Specifies inducible resistance to macrolides, lincosamides and streptogramin type B (MLS) antibiotics. Originally isolated from Streptococcus sanguis. |
Distributed in: | Bacillus subtilis subsp. subtilis 1E34 (derivative of strain 168) |
Cultivation conditions: | Medium 381+ 40 μg/ml thymine, 30°C |
Risk group: | 1 (classification according to German TRBA) |
Restrictions: | no |
Country: | country of origin unknown |
Date of sampling: | before 16.03.1990 |
Nagoya Protocol Restrictions: | There are NO known Nagoya protocol restrictions for this strain. |
Supplied as: | Delivery form | | Organization type | | | | Profit | | Non-Profit | | | Freeze Dried | | 100,- € | | 100,- € | | Active culture on request | | 240,- € | | 240,- € | |
Price category 1 strain. Please see price list for freight and handling charges |
| Print data sheet |